Literature DB >> 7644464

Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11.

M Karayiorgou1, M A Morris, B Morrow, R J Shprintzen, R Goldberg, J Borrow, A Gos, G Nestadt, P S Wolyniec, V K Lasseter.   

Abstract

We report the results of two studies examining the genetic overlap between schizophrenia and velocardiofacial syndrome. In study A, we characterize two interstitial deletions identified on chromosome 22q11 in a sample of schizophrenic patients. The size of the deletions was estimated to be between 1.5 and 2 megabases. In study B, we examine whether variations in deletion size are associated with the schizophrenic phenotype in velocardiofacial syndrome patients. Our results show that a region of the genome that has been previously implicated by genetic linkage analysis can harbor genetic lesions that increase the susceptibility to schizophrenia. Our findings should facilitate identification and cloning of the schizophrenia susceptibility gene(s) in this region and identification of more homogeneous subgroups of patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7644464      PMCID: PMC41195          DOI: 10.1073/pnas.92.17.7612

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients.

Authors:  F M Benes; J McSparren; E D Bird; J P SanGiovanni; S L Vincent
Journal:  Arch Gen Psychiatry       Date:  1991-11

2.  Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development.

Authors:  S Akbarian; A Viñuela; J J Kim; S G Potkin; W E Bunney; E G Jones
Journal:  Arch Gen Psychiatry       Date:  1993-03

3.  Implications of normal brain development for the pathogenesis of schizophrenia.

Authors:  D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1987-07

4.  Follow-up report of potential linkage for schizophrenia on chromosome 22q: Part 3.

Authors:  V K Lasseter; A E Pulver; P S Wolyniec; G Nestadt; D Meyers; M Karayiorgou; D Housman; S Antonarakis; H Kazazian; L Kasch
Journal:  Am J Med Genet       Date:  1995-04-24

5.  Velo-cardio-facial syndrome: language and psychological profiles.

Authors:  K J Golding-Kushner; G Weller; R J Shprintzen
Journal:  J Craniofac Genet Dev Biol       Date:  1985

6.  Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia.

Authors:  S E Arnold; B T Hyman; G W Van Hoesen; A R Damasio
Journal:  Arch Gen Psychiatry       Date:  1991-07

7.  Availability of schizophrenic patients and their families for genetic linkage studies: findings from the Maryland epidemiology sample.

Authors:  A E Pulver; S J Bale
Journal:  Genet Epidemiol       Date:  1989       Impact factor: 2.135

8.  Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus.

Authors:  P J Scambler; D Kelly; E Lindsay; R Williamson; R Goldberg; R Shprintzen; D I Wilson; J A Goodship; I E Cross; J Burn
Journal:  Lancet       Date:  1992-05-09       Impact factor: 79.321

9.  Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome.

Authors:  D A Driscoll; N B Spinner; M L Budarf; D M McDonald-McGinn; E H Zackai; R B Goldberg; R J Shprintzen; H M Saal; J Zonana; M C Jones
Journal:  Am J Med Genet       Date:  1992-09-15

10.  Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development.

Authors:  S Akbarian; W E Bunney; S G Potkin; S B Wigal; J O Hagman; C A Sandman; E G Jones
Journal:  Arch Gen Psychiatry       Date:  1993-03
View more
  196 in total

Review 1.  Update on childhood-onset schizophrenia.

Authors:  J L Rapoport; G Inoff-Germain
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

Review 2.  Genetic insights into schizophrenia.

Authors:  A S Bassett; E W Chow; D M Waterworth; L Brzustowicz
Journal:  Can J Psychiatry       Date:  2001-03       Impact factor: 4.356

Review 3.  Genetics of schizophrenia and the new millennium: progress and pitfalls.

Authors:  M Baron
Journal:  Am J Hum Genet       Date:  2001-01-17       Impact factor: 11.025

4.  Patterns of dysmorphic features in schizophrenia.

Authors:  L E Scutt; E W Chow; R Weksberg; W G Honer; A S Bassett
Journal:  Am J Med Genet       Date:  2001-12-08

5.  A compelling genetic hypothesis for a complex disease: PRODH2/DGCR6 variation leads to schizophrenia susceptibility.

Authors:  Aravinda Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

6.  Loss of Goosecoid-like and DiGeorge syndrome critical region 14 in interpeduncular nucleus results in altered regulation of rapid eye movement sleep.

Authors:  Hiromasa Funato; Makito Sato; Christopher M Sinton; Laurent Gautron; S Clay Williams; Amber Skach; Joel K Elmquist; Arthur I Skoultchi; Masashi Yanagisawa
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

7.  Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion.

Authors:  Liam J Drew; Kimberly L Stark; Karine Fénelon; Maria Karayiorgou; Amy B Macdermott; Joseph A Gogos
Journal:  Mol Cell Neurosci       Date:  2011-05-24       Impact factor: 4.314

8.  Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia.

Authors:  Vidyulata Kamath; Paul J Moberg; Raquel E Gur; Richard L Doty; Bruce I Turetsky
Journal:  Behav Neurosci       Date:  2011-12-12       Impact factor: 1.912

Review 9.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

Review 10.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.